Our global leadership in schizophrenia is well known throughout industry and academia. We support numerous clinical and neurocognitive endpoints, including assessment of at-risk status, conversion to psychosis, and functional capacity. We also support clinical development programs in bipolar disorder, major depressive disorder, post-traumatic stress disorder, attention-deficit disorder, and other conditions affecting mental health and cognition.

Areas of expertise include

  • ADHD
  • ALS
  • Alzheimer's
  • Bipolar disorder
  • Dementia
  • MS
  • Migraine
  • Post-traumatic stress
  • Schizophrenia